Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a liver condition in which excess fat builds up in the liver in people with metabolic risk factors. 

MASLD ranks as the most prevalent chronic liver condition worldwide and contributes more than any other cause to liver-related complications and deaths. 

At Bay Biosciences, we provide high-quality human biospecimens that help support liver disease research, including MASLD Serum and Plasma Samples, Liver Disease Research Samples, and Fatty Liver Disease Samples. 

Understanding MASLD

Metabolic dysfunction-associated steatotic liver disease refers to fat accumulation in liver cells in individuals with at least one metabolic risk factor, such as obesity or abnormal blood lipids, and little or no alcohol intake.

MASLD can range from simple fat accumulation to a more severe form called metabolic dysfunction-associated steatohepatitis (MASH). 

MASH involves liver inflammation and cell damage. Over time, it can lead to liver fibrosis, cirrhosis, and, in some cases, liver cancer.

Because the disease develops through many metabolic and inflammatory pathways,Fatty Liver Disease Samples are valuable for studies of disease progression, biomarkers, and treatment response.

Stages of MASLD

In the first stage, fat collects in the liver without major inflammation or cell injury. In the next stage, MASH develops, and ongoing inflammation damages liver cells.

If the damage continues, scar tissue forms and leads to liver fibrosis. Advanced scarring can then progress to cirrhosis, which changes the structure of the liver and reduces its function.

This variation between patients is one reason researchers need MASLD Samples from different disease stages.

Symptoms of MASLD

MASLD often causes no symptoms in its early stages. Many people only find out they have it after routine blood tests or imaging done for another reason.

When symptoms do appear, they may include fatigue, discomfort in the upper right abdomen, or an enlarged liver. 

In advanced disease, jaundice and abdominal swelling can occur, as liver scarring progresses to cirrhosis.

However, these symptoms alone cannot confirm MASLD. A healthcare professional must evaluate the patient before making a diagnosis.

Causes/ Risk Factors of MASLD

1. Obesity

Excess body fat, especially around the abdomen, is closely linked to fat buildup in the liver. Obesity is one of the most common risk factors for MASLD.

2. Type 2 Diabetes and Insulin Resistance

Insulin resistance can increase fat storage in the liver. People with type 2 diabetes have a higher likelihood of developing MASLD and of progressing to more advanced disease.

3. Abnormal Blood Lipids

High levels of cholesterol and triglycerides are commonly seen in people with MASLD.

4. Metabolic Syndrome

MASLD often occurs alongside a cluster of conditions that includes high blood pressure, raised blood sugar, and abnormal lipids. These are described together as metabolic syndrome.

5. Lifestyle Factors

A sedentary lifestyle and a poor diet can increase the risk of fat accumulation in the liver.

Diagnosis of MASLD

Healthcare professionals usually begin by reviewing the patient’s medical history, risk factors, alcohol intake, and physical findings. They also rule out other causes of liver disease.

Liver function tests can show elevated liver enzymes, although some people with MASLD have normal results.

Imaging techniques such as ultrasound, CT, or MRI are also used as they help detect fat in the liver. Ultrasound is often the first choice because it is safe, widely available, and low in cost. A fatty liver looks brighter than normal on the scan. However, ultrasound may miss mild fat buildup. CT shows fatty liver as an area that looks darker than normal. MRI is the most accurate option, and special MRI methods can measure the exact amount of fat in the liver.

A biopsy may be done in some cases to confirm inflammation and fibrosis. During this procedure, a doctor removes a small piece of liver tissue with a thin needle.

A pathologist then examines the sample under a microscope and looks out for fat, inflammation, liver cell injury, and scarring. 

Treatment of MASLD

Treatment focuses on managing the underlying metabolic risk factors. 

Clinicians commonly recommend regular exercise, a balanced diet, and gradual weight loss for people who are overweight.

Doctors also treat associated conditions such as diabetes, high cholesterol, and high blood pressure. For some patients with MASH and significant fibrosis, clinicians may consider medication therapy.

Overall, treatment depends on disease stage and individual patient factors, so a healthcare professional should guide the plan.

Importance of Serum and Plasma in MASLD Research

Because liver biopsy is invasive and cannot be repeated easily, blood-based samples offer a more practical way to study MASLD and track changes across patient groups over time. 

Both serum and plasma carry proteins, lipids, hormones, and signaling molecules that reflect what is happening in the liver, so researchers can measure these molecules to better understand inflammation, metabolic stress, and liver injury. 

In addition, these samples are compatible with many laboratory platforms, including immunoassays, proteomics, and metabolomics, which means a single sample can support several types of analysis and help researchers build a more complete picture of the disease.

Frequently Asked Questions

Can MASLD Serum and Plasma Samples support biomarker research?

Yes. Researchers can analyze MASLD Serum Samples and MASLD Plasma Samples for inflammatory markers, lipid profiles, liver enzymes, proteins, and other molecules that may serve as research biomarkers.

Are Liver Disease Samples available for different stages of disease?

Liver Disease Research Samples can cover conditions such as fatty liver disease, NASH, fibrosis, and cirrhosis.

Can researchers compare Metabolic Dysfunction-Associated Steatotic Liver Disease Samples with healthy controls?

Yes. Researchers can compare disease groups with normal healthy donor samples to identify differences in biomarkers and metabolic profiles.

Are Bay Biosciences’ human biospecimens ethically sourced?

Yes. We collect all samples through appropriate consent and IRB-approved protocols.

Supporting Your Research with Bay Biosciences

At Bay Biosciences, we have a comprehensive range of high-quality human biospecimens.

Some of these include:

If you have any questions, concerns, or special requests, please don’t hesitate to reach out to us!